Investigative Site Number: 1003 — Anderson, South Carolina

Investigative Site Number: 1003 is a clinical research site located in Anderson, South Carolina, United States 29621-2062.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigative Site Number: 1003 has participated in 1 clinical trials.

Therapeutic areas: Eczema, Atopic Dermatitis.

Sponsors: Kymab Limited.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Anderson

Browse all research sites in South Carolina · View every site in Anderson

• AnMed Health Hospital
• AnMed Health Cancer Center
• AnMed Cancer Center
• Research Site
• Radiant Research
• AnMed Health
• GSK Investigational Site
• Velocity Clinical Research-Anderson
• Rose Ramer Cancer Clinic at Anderson Area Medical Center
• Synexus Clinical Research US Inc
• AnMed Health Medical Center
• Hartwell Research Group

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site Number: 1003?

Investigative Site Number: 1003 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site Number: 1003 conducted?

Investigative Site Number: 1003 has 1 clinical trials on record. Their work covers Eczema, Atopic Dermatitis.

Is Investigative Site Number: 1003 accredited by Crixeo Clinical Trials?

Investigative Site Number: 1003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site Number: 1003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.